Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126513853 | 12651385 | 3 | F | 20160715 | 20160913 | 20160815 | 20160927 | EXP | CZ-CZSUKL-16002676 | CZ-EMD SERONO-E2B_80047405 | EMD SERONO INC | 30.90 | YR | F | Y | 85.00000 | KG | 20160927 | MD | CZ | CZ |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126513853 | 12651385 | 1 | PS | REBIF | INTERFERON BETA-1A | 1 | Subcutaneous | N | 103780 | 44 | UG | INJECTION | TIW | ||||||
126513853 | 12651385 | 2 | C | CITALOPRAM | CITALOPRAM HYDROBROMIDE | 1 | Oral | FORM STRENGTH: 20 (UNSPECIFIED UNITS) | 0 | FILM-COATED TABLET | QD |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
126513853 | 12651385 | 1 | Multiple sclerosis relapse |
126513853 | 12651385 | 2 | Depression |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
126513853 | 12651385 | HO |
126513853 | 12651385 | DS |
126513853 | 12651385 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
126513853 | 12651385 | Dyspnoea | |
126513853 | 12651385 | Pulmonary hypertension |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
126513853 | 12651385 | 1 | 20130401 | 20160725 | 0 | |
126513853 | 12651385 | 2 | 20070522 | 20160728 | 0 |